Canary Advisors®
Canary Advisors® partners with biopharma, nonprofit, and regulatory stakeholders to better align clinical development programs with patient wants and needs. There's no one size fits all solution to advocacy. Our services are tailor-made to match the needs of the patient communities our partners serve.
Our Approach
We work with our biopharmaceutical, nonprofit, and regulatory partners to better understand disease impacts, unmet needs, and patient preferences.
Our Services
-
Early Stage Patient Advocacy
-
Regulatory Patient Advocacy
-
Access & Reimbursement Support
-
Clinical Trial Patient Support
-
Patient Experience Data Collection to Support Regulatory Submissions
-
White Glove Clinical Trial Concierge
Our team
-
Jenn McNary
Co-Founder & CEO
Educator and advocate with 20 years experience on the front lines of rare disease clinical development; drug approval and reimbursement; and advocacy.
-
Richie Kahn
Co-Founder & COO
Clinical researcher and patient advocate with 14 years experience working to better incorporate the patient perspective into the clinical development process.
-
Karen Utley
Patient Advocacy Associate
RN and advocate with 15 years experience; highly skilled at relationship building and clinical trial education in rare and ultra rare communities
-
Liz Carter
Patient Advocacy Associate
Educator; multilingual rare disease patient advocate & engagement specialist; and newborn screening ambassador
-
Carolina Consuegra
Medical Writer
Multilingual medical writer; communications strategist; and advocate
-
Ashley Hamic
Operations Manager
PMP-certified project manager with 18 years of corporate experience, rare disease mom and advocate, and founder of Wish Wear Accessories.
Featured Work
The links listed below open a new window.
-
Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials?
Recognizing Patients' Wants And Needs Benefits Sponsors, Regulators, And, Of Course, Patients
Why Including Patients in FDA Engagement Will Benefit Your Trial
Best Practices For Identifying And Partnering With Patient Advocacy Organizations
-
-